B Orhan, B Malbora, SA Bayar, Z Avcı, B Alioğlu… - Turk J …, 2016 - oftalmoloji.org
Objectives: Ophthalmologic disease in patients with acute leukemia occurs due to primary leukemic infiltration (involvement), or secondary to the disease and its treatment. In recent …
B Orhan, B Malbora, SA Bayar, Z Avcı, B Alioğlu… - Turk J …, 2016 - core.ac.uk
Results: Among the patients, 83 (69.2%) were diagnosed with acute lymphoblastic leukemia, 35 (29.1%) with acute myeloblastic leukemia, and 2 (1.7%) with mixed-lineage …
B Orhan, B Malbora, Z Avcı, B Alioğlu… - Turkish Journal of …, 2016 - europepmc.org
Objectives Ophthalmologic disease in patients with acute leukemia occurs due to primary leukemic infiltration (involvement), or secondary to the disease and its treatment. In recent …
B Orhan, B Malbora, SA Bayar… - Turkish journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Objectives Ophthalmologic disease in patients with acute leukemia occurs due to primary leukemic infiltration (involvement), or secondary to the disease and its treatment. In recent …
B Orhan, B Malbora, SA Bayar, Z Avci… - Turkish Journal of …, 2016 - go.gale.com
Objectives: Ophthalmologic disease in patients with acute leukemia occurs due to primary leukemic infiltration (involvement), or secondary to the disease and its treatment. In recent …
B Orhan, B Malbora, SA Bayar, Z Avcı… - Turkish Journal of …, 2016 - search.ebscohost.com
Objectives: Ophthalmologic disease in patients with acute leukemia occurs due to primary leukemic infiltration (involvement), or secondary to the disease and its treatment. In recent …
B Orhan, B Malbora, SA Bayar, Z Avci… - Turk Oftalmoloji …, 2016 - search.proquest.com
Objectives: Ophthalmologic disease in patients with acute leukemia occurs due to primary leukemic infiltration (involvement), or secondary to the disease and its treatment. In recent …
B Orhan, B Malbora, SA Bayar, Z Avcı… - Turk J …, 2016 - pdfs.semanticscholar.org
Results: Among the patients, 83 (69.2%) were diagnosed with acute lymphoblastic leukemia, 35 (29.1%) with acute myeloblastic leukemia, and 2 (1.7%) with mixed-lineage …